Improved
6112 HealthChanged
3786 LivesSaved
3568 Lives0 lives impacted in the last 24 hrs Learn More
Dr. Singh explains if ovarian cancer treatments can cause sexual dysfunction.
Dr. Singh:
Surgery, chemo, menopause, can all influence sexual dysfunction. That’s a really important area and one that, you know, is fraught with a little bit of difficulty because I talked a little about what causes potentially ovarian cancer. What are the risks and other things, and we know there’s hormonal relationships. So that’s one of the areas that’s a little bit tricky.
There’s data that shows that hormone replacement therapy probably increases the risk of ovarian cancer, and we use anti-hormonal therapies, the treatment we didn’t talk about, for certain kinds of ovarian cancers and for certain settings.
And so dealing with the side effects of menopause, dealing with the body changes that happen, dealing with the other parts of things like losing your hair and not feeling beautiful or not feeling feminine, I mean, all of those things are things that impact on sexual function, but they can all be addressed in different ways, and we have our tools to deal with vaginal dryness, we have our tools to deal with hot flashes, there’s lots of things we can do.
About Dr. Diljeet K. Singh, M.D., Dr.P.H.:
Dr. Diljeet K. Singh, M.D., Dr.P.H., is a gynecologic oncologist and is Co-Director of the Northwestern Ovarian Cancer Early Detection and Prevention Program. She is part of the Division of Gynecologic Oncology at the Robert H. Lurie Comprehensive Cancer Center of the Feinberg School of Medicine at Northwestern University in Chicago, Illinois.
Dr. Singh attended medical school at the Feinberg School of Medicine at Northwestern University. She completed her residency at Johns Hopkins Hospital in Baltimore, Maryland, and her fellowship at the University of Texas MD Anderson Cancer Center in Houston, Texas.
Dr. Singh specializes in gynecologic, cervical, ovarian, uterine, vaginal, and vulvar cancers.